Form 4 · Filed Jun 1, 2026, 08:22 PM UTC
ESPR/Esperion Therapeutics, Inc.
CARROLL J MARTIN — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
1 row| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 28, 2026 | A | other | 79,873 | $0 | — | 177,523 |
Source: SEC EDGAR raw filing ↗ · Accession 0001628280-26-039520